Manual methods of blood glucose monitoring are labor-intensive, costly, prone to error, and expose the caregiver to blood. The VIA® blood chemistry monitor for glucose can automatically measure plasma glucose (PG) every 5 minutes for 72 hours using blood sampled from a peripheral vein/artery or a central vein.
Methods:
VIA performance was evaluated in eight normal and five type 1 diabetic (T1DM) subjects in 15 separate experiments. The VIA device was connected to a peripheral vein and reported a PG value every 5 minutes during each 510-minute experiment. Blood samples were collected manually every 10 minutes and assayed using a HemoCue® β-glucose analyzer (HC). Whole blood HC measurements were corrected to PG values. Paired HC/VIA measurements (n = 717) were analyzed.
Results:
Mean PG was 90 ± 14 and 96 ± 12 mg/dl in normal subjects and 194 ± 64 and 173 ± 48 mg/dl in T1DM subject as measured by the HC and VIA, respectively. Clark error grid analysis revealed 86% points in zone A, 11% points in zone B, and 2% points in zone D. Linear regression analysis yielded the following equation: VIA = 0.732 × HC + 30.5 (r2 = 0.954). Residual analysis revealed a glucose-dependent bias between the HC and the VIA. VIA data were transformed using the linear regression equation to correct for bias. After the correction, the mean absolute relative difference between the VIA and the HC was less than 10%, and 99.6% of data were in zones A and B. The VIA was able to sample blood automatically every 5 minutes for more than 8 hours in the laboratory setting. On average, the VIA reported glucose values for 94% of the samples it attempted to obtain.
Conclusions:
This study demonstrated that the VIA blood chemistry monitor for glucose can reliably sample blood frequently for a prolonged period of time safely and effectively in diabetic and nondiabetic volunteers. Agreement between the two devices was the closest at normal glucose concentrations. After correcting for a glucose-dependent bias between the devices, the MARD was consistently less than 10% for all glucose ranges.
CryerPE. Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill?. Diabetologia. 2006; 49 (8): 1722–5.
2.
FurnaryAPZerrKJGrunkemeierGLStarrA. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999; 67 (2): 352–60; discussion 360–2.
3.
KrinsleyJSGroverA. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007; 35 (10): 2262–7.
4.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001; 345 (19): 1359–67.
5.
Van den BergheGWoutersPJBouillonRWeekersFVerwaestCSchetzMVlasselaersDFerdinandePLauwersP. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003; 31 (2): 359–66.
6.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2; 354 (5): 449–61.
7.
LevetanCSSalasJRWiletsIFZumoffB. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995; 99 (1): 22–8.
8.
LevetanCSMageeMF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000; 29 (4): 745–70.
BlakeDRNathanDM. Point-of-care testing for diabetes. Crit Care Nurs Q. 2004; 27 (2): 150–61.
11.
ClementSBraithwaiteSSMageeMFAhmannASmithEPSchaferRGHirschIB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 27 (2): 553–91.
EllmererMHaluzikMBlahaJKremenJSvacinaSTollerWMaderJSchauppLPlankJPieberT. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care. 2006; 29 (6): 1275–81.
14.
AtkinSHDasmahapatraAJakerMAChorostMIReddyS. Fingerstick glucose determination in shock. Ann Intern Med. 1991; 114 (12): 1020–4.
15.
KulkarniASaxenaMPriceGO'LearyMJJacquesTMyburghJA. Analysis of blood glucose measurements using capillary and arterial blood samples in intensive care patients. Intensive Care Med. 2005; 31 (1): 142–5.
16.
RayJGHamielecCMastracciT. Pilot study of the accuracy of bedside glucometry in the intensive care unit. Crit Care Med. 2001; 29 (11): 2205–7.
17.
SylvainHFPokornyMEEnglishSMBensonNHWhitleyTWFerenczyCJHarrisonJG. Accuracy of fingerstick glucose values in shock patients. Am J Crit Care. 1995; 4 (1): 44–8.
18.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005; 33 (12): 2778–85.
19.
KagelEMRayanGM. Intravenous catheter complications in the hand and forearm. J Trauma. 2004; 56 (1): 123–7.
20.
MohlerMSatoYBobickKWiseLC. The reliability of blood sampling from peripheral intravenous infusion lines. Complete blood cell counts, electrolyte panels, and survey panels. J Intraven Nurs. 1998; 21 (4): 209–14.
21.
SeemannSReinhardtA. Blood sample collection from a peripheral catheter system compared with phlebotomy. J Intraven Nurs. 2000; 23 (5): 290–7.
22.
Becan-McBrideK. Laboratory sampling. Does the process affect the outcome?. J Intraven Nurs. 1999; 22 (3): 137–42.
23.
KuwaKNakayamaTHoshinoTTominagaM. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin Chim Acta. 2001; 307 (1–2): 187–92.
24.
YuchaCBDeAngeloE. The minimum discard volume: accurate analysis of peripheral hematocrit. J Intraven Nurs. 1996; 19 (3): 141–6.
25.
O'HareDChilversRJ. Arterial blood sampling practices in intensive care units in england and wales. Anaesthesia. 2001; 56 (6): 568–71.
26.
FloodJJosephJKimLMcNultySChervonevaI. Glucose levels in blood simultaneously sampled from the radial artery, vena cava, and fingertip. Anesthesiology. 2007; 107: A1123.
27.
JosephJ. Anesthesia and surgery in the diabetic patient. In: GoldsteinBJMuller-WielandD, editors. Textbook of type 2 diabetes. Informa Healthcare; 2003. p. 393–408.
28.
American diabetes association: Clinical practice recommendations 1996. Diabetes Care. 1996; 19Suppl 1: S1–118.
29.
Requirements for in vitro blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/TC 212/WG 3. In: Draft International Standard ISO/DIS 15197. ISO 2001 ed. Geneva, Switzerland: International Organization for Standardization.
30.
LacaraTDomagtoyCLickliterDQuattrocchiKSnipesLKuszajJPrasnikarM. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care. 2007; 16 (4): 336–46; quiz 347.
31.
MannEAPidcokeHFSalinasJWadeCEHolcombJBWolfSE. Accuracy of glucometers should not be assumed. Am J Crit Care. 2007; 16 (6): 531–2; author reply 532.
32.
KostGJVuHTLeeJHBourgeoisPKiechleFLMartinCMillerSSOkoroduduAOPodczasyJJWebsterRWhitlowKJ. Multicenter study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the united states and canada. Crit Care Med. 1998; 26 (3): 581–90.
33.
BochicchioGVSungJJoshiMBochicchioKJohnsonSBMeyerWScaleaTM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma. 2005; 58 (5): 921–4.
34.
CapesSEHuntDMalmbergKGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355 (9206): 773–8.
35.
FinneySJZekveldCEliaAEvansTW. Glucose control and mortality in critically ill patients. JAMA. 2003; 290 (15): 2041–7.
36.
GoldenSHPeart-VigilanceCKaoWHBrancatiFL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999; 22 (9): 1408–14.
37.
KrinsleyJS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78 (12): 1471–8.
38.
KrinsleyJS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79 (8): 992–1000.
39.
LazarHLChipkinSRFitzgeraldCABaoYCabralHApsteinCS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004; 109 (12): 1497–502.
40.
MalmbergKRydénLEfendicSHerlitzJNicolPWaldenströmAWedelHWelinL. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995; 26 (1): 57–65.
41.
OuattaraALecomtePLe ManachYLandiMJacqueminetSPlatonovIBonnetNRiouBCoriatP. Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology. 2005; 103 (4): 687–94.
42.
PomposelliJJBaxterJK3rdBabineauTJPomfretEADriscollDFForseRABistrianBR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998; 22 (2): 77–81.
43.
UmpierrezGEIsaacsSDBazarganNYouXThalerLMKitabchiAE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87 (3): 978–82.
44.
ZerrKJFurnaryAPGrunkemeierGLBookinSKanhereVStarrA. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997; 63 (2): 356–61.
45.
EgiMBellomoRStachowskiEFrenchCJHartG. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006; 105 (2): 244–52.
46.
HirschIBBrownleeM. Should minimal blood glucose variability become the gold standard of glycemic control?. J Diabetes Complications. 2005; 19 (3): 178–81.
47.
BraithwaiteSSBuieMMThompsonCLBaldwinDFOertelMDRobertsonBAMehrotraHP. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004; 10Suppl 2: 89–99.
48.
DevosPPreiserJC. Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU?. Crit Care. 2006; 10 (2): 130.
49.
DevosPPreiserJC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care. 2007; 10 (2): 206–9.
50.
FischerKFLeesJANewmanJH. Hypoglycemia in hospitalized patients. causes and outcomes. N Engl J Med. 1986; 315 (20): 1245–50.
51.
GluControl study: Comparing the effects of two glucose control regimens by insulin in intensive care unit patients [homepage on the Internet]. U.S. National Institutes of Health [cited 2007 Nov]. Available from: http://clinicaltrials.gov/show/NCT00107601
52.
MitchellIFinferSBellomoRHiglettT, ANZICS Clinical Trials Group Glucose Management Investigators. Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study. Intensive Care Med. 2006 Jun; 32 (6): 867–74.
53.
Stagnaro-GreenABartonMKLinekinPLCorkeryEdeBeerK. Roman SH. Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med. 1995; 62 (6): 422–6.
54.
ThomasANBoxallEMTwamleyHW. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2007; 35 (4): 1218–9; author reply 1219.
55.
A multi-centre, open label randomised stratified controlled trial of the effects of blood glucose management on 90-day all-cause mortality in a heterogeneous population of intensive care unit (ICU) patients [homepage on the Internet]. BioMed Central [cited 2007 Nov]. Available from: http://controlled-trials.com/ISRCTN04968275/ISRCTN04968275.
56.
VriesendorpTMDeVriesJHvan SantenSMoeniralamHSde JongeERoosYBSchultzMJRosendaalFRHoekstraJB. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2006; 34 (11): 2714–8.
57.
WexlerDJMeigsJBCaglieroENathanDMGrantRW. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007; 30 (2): 367–9.
58.
ZanderRBoldtJEngelmannLMertzlufftFSirtlCStuttmannR. The design of the VISEP trial. Critical appraisal. Anaesthesist. 2007; 56 (1): 71–7.
59.
BrunkhorstFMEngelCBloosFMeier-HellmannARagallerMWeilerNMoererOGruendlingMOppertMGrondSOlthoffDJaschinskiUJohnSRossaintRWelteTSchaeferMKernPKuhntEKiehntopfMHartogCNatansonCLoefflerMReinhartK; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 358 (2): 125–39.
60.
KaganskyNLevySRimonECojocaruLFridmanAOzerZKnoblerH. Hypoglycemia as a predictor of mortality in hospitalized elderly patients. Arch Intern Med. 2003; 163 (15): 1825–9.
61.
TaylorBESchallomMESonaCSBuchmanTGBoyleWAMazuskiJESchuererDEThomasJMKaiserCHueyWYWardMRZackJECoopersmithCM. Efficacy and safety of an insulin infusion protocol in a surgical ICU. J Am Coll Surg. 2006; 202 (1): 1–9.
62.
AragonD. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006; 15 (4): 370–7.
63.
BaileyPLMcJamesSWCluffMLWellsDTOrrJAWestenskowDRKernSE. Evaluation in volunteers of the VIA V-ABG automated bedside blood gas, chemistry, and hematocrit monitor. J Clin Monit Comput. 1998; 14 (5): 339–46.
64.
BalogaJMEdelmanSV. Use of a real-time glucose sensor (VIA model 121) for glucose clamp studies (#519). Diabetes. 1996; 45 (Suppl 2): 142A.
65.
LucisanoJYEdelmanSVQuintoBDWongDK. Development of a biosensor-based, patient-attached blood glucose monitoring system. Proc Am Chem Soc. 1997; 76: 256.
66.
VIA blood chemistry monitor for glucose VIA V-GLU 1 operator's manual. San Diego, CA: VIA Medical Corporation; 1998.
TorjmanMCJahnLJosephJICrothallK. Accuracy of the hemocue portable glucose analyzer in a large nonhomogeneous population. Diabetes Technol Ther. 2001; 3 (4): 591–600.
69.
VossEMCembrowskiGS. Performance characteristics of the HemoCue B-glucose analyzer using whole-blood samples. Arch Pathol Lab Med. 1993; 117 (7): 711–3.
70.
HipszerBJosephJKamM. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes. Diabetes Technol Ther. 2005; 7 (1): 83–93.
71.
IFCC recommendation on reporting results for blood glucose. Clinica Chim Acta. 2001; 307 (1–2): 205–9.
72.
Fogh-AndersenND'OrazioP. Proposal for standardizing direct-reading biosensors for blood glucose. Clin Chem. 1998; 44 (3): 655–9.
WidnessJAKulhavyJCJohnsonKJCressGAKromerIJAcarreguiMJFeldRD. Clinical performance of an in-line point-of-care monitor in neonates. Pediatrics. 2000; 106 (3): 497–504.
75.
Coss-BuJAJeffersonLSStone-McCordSOuCNWatrinCSachdevaRCopelandKC. Evaluation of a real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract. 1999; 44 (3): 175–81.
76.
CousinsTRO'DonnellJM. Arterial cannulation: a critical review. AANA J. 2004; 72 (4): 267–71.
77.
MartinCSauxPPapazianLGouinF. Long-term arterial cannulation in ICU patients using the radial artery or dorsalis pedis artery. Chest. 2001; 119 (3): 901–6.
78.
WallachSG. Cannulation injury of the radial artery: diagnosis and treatment algorithm. Am J Crit Care. 2004; 13 (4): 315–9.
79.
HosteEARoelsNRDecruyenaereJMColardynFA. Significant increase of activated partial thromboplastin time by heparinization of the radial artery catheter flush solution with a closed arterial catheter system. Crit Care Med. 2002; 30 (5): 1030–4.
80.
LewJKHutchinsonRLinES. Intra-arterial blood sampling for clotting studies. Effects of heparin contamination. Anaesthesia. 1991; 46 (9): 719–21.
DahlbergMWhitelawA. Evaluation of HemoCue blood glucose analyzer for the instant diagnosis of hypoglycaemia in newborns. Scand J Clin Lab Invest. 1997; 57 (8): 719–24.
83.
AshworthLGibbIAlbertikg. HemoCue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem. 1992; 38 (8 Pt 1): 1479–82.
84.
BurrinJMAlbertikg. What is blood glucose: can it be measured?. Diabet Med. 1990; 7 (3): 199–206.
85.
ElimamAHoralMBergstromMMarcusC. Diagnosis of hypoglycaemia: effects of blood sample handling and evaluation of a glucose photometer in the low glucose range. Acta Paediatr. 1997; 86 (5): 474–8.
86.
M'BembaJChevalierABruzzoFSlamaGSelamJL. Usefulnes of the hemocue blood glucose photometer in hypoglycaemic conditions. Diabet Med. 1997; 14 (8): 711.
87.
RassamAGMcleodJBurgeMRSchadeDS. Use of the HemoCue blood glucose analyzer in research studies. Diabetes Care. 1998; 21 (8): 1369–70.
88.
WienerK. An assessment of the effect of haematocrit on the HemoCue blood glucose analyser. Ann Clin Biochem. 1993; 30 (Pt 1): 90–3.
89.
YoungRPCritchleyJALauMSLeeKKRobertshawAMChanTYAndersonDC. Reliability of glucose measurement using the HemoCue analyser in hypoglycaemia. Ann Clin Biochem. 1994; 31 (Pt 6): 573–5.
